楼主: ribosome
1432 1

[营销模式] 医药营销新兴模式 [推广有奖]

  • 4关注
  • 1粉丝

已卖:1038份资源

讲师

8%

还不是VIP/贵宾

-

威望
0
论坛币
2345 个
通用积分
37.1089
学术水平
0 点
热心指数
0 点
信用等级
0 点
经验
8644 点
帖子
154
精华
0
在线时间
408 小时
注册时间
2007-10-28
最后登录
2024-9-25

楼主
ribosome 发表于 2015-1-12 08:36:48 |AI写论文

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
 Introduction……………………………………………..….……………………….
 Market Structure and Overview………………………………………………….
 Factors Increasing Market Size…………………………………………
 Market Restraints………………………………………………………….
 Dynamic Shifts in Pharma Market …..…………………………………
 Geographic Overview & Landscaping…………………………………
 Trends……………………………………………………………………………..
 Long Term Strategies
 Long Term Strategies - Forward Integration Model…………………
 Long Term Strategies - Targeted Treatment Solutions……………….
 Long Term Strategies - Biotech and Genomics………………………
 Network Model
 Network Model - Outsourcing…………………………………………
 Network Model - In-licensing vs. Out-licensing…………………………
 Network Model - Product Life Cycle Management……………………
 Short Term Strategies
 Short Term Strategies - Semi Block Buster Model…………………….
 Short Term Strategies - Pre- and Post-patent Based ……………….
 Short Term Strategies Against Parallel Trade…………………………
 Mergers & Acquisitions………………………………………………………….
 Market Forecasting & New Revenue Models………………………………….
 The Winning Proposition…………………………………………………………
Benchmarking of the Main Players
By Revenues……………………………………………………….
By Employees………………………......……………………………
Top 20 Drugs by Sales………………………………………………
Top 20 Drugs by Percentage Increase in Sales………………….
By Percentage Growth in Operating Margins…………………….
By Percentage Growth in Revenues…………………………….
By Geographic wise Revenue Growth………………………….
By DTC Spending………………………………………………….
Key SWOT Analysis of Top 10 Companies………………………
Patents Expiring………………………………………………………
Company Profiles
Pfizer Inc…………………………………………………………....
GlaxoSmithKline plc………………………………………………
Merck & Co…………………………………………………………
Aventis………………………………………………………………
Bristol Myers Squibb……………………………………………...
Johnson n Johnson………………………………………………….
AstraZeneca……………………………………………………….
Wyeth…………………………………………………………………
Novartis………………………………………………………………
Eli Lily……………………………………………………………….
Conclusions…………………………………………………………………..

Emerging Business Models.pdf (1.04 MB, 需要: 1 个论坛币)

二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:医药营销 Benchmarking introduction Acquisitions proposition 医药营销 新兴

沙发
oink-oink(未真实交易用户) 发表于 2015-1-12 13:14:11
提示: 作者被禁止或删除 内容自动屏蔽

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
jg-xs1
拉您进交流群
GMT+8, 2025-12-25 14:23